Sangamo Therapeutics Inc.

(SGMO) Trade

By |

Profile

Sangamo Therapeutics Inc is a clinical stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy.

Contact Information

Website: www.sangamo.com
Main Phone: +1 510 970-6000
Address: 501 Canal Boulevard
State: CA
City / Town: Richmond
Country: USA
Postal Code: 94804

Issuer Information

Exchange: NGS
CEO: Alexander Macrae
Employees: 131
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare
NAICS: Biological Produ
$ 14.63 $ 0.025 (0.17%)
Last Price 14.63 Change $ 0.025 Change % 0.17 Tick N/A
Bid 12.90 Bid Size 500.00 Ask N/A Ask Size 0.00
Open 14.55 High 14.95 Low 14.35 Prev Close 14.60
Last Trade Volume 1.1 mi 52 Wk Hi 17.06 52 Wk Low 2.65
Market Cap 1.2 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 84,520,951.00 EPS (TTM) -0.69 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 6 24
Number of Buys 0 4
Number of Sells 6 20
Net Activity -134642 -46810
Last 10 Buys Shares
H. Ward Wolff 1,000
Edward O. Lanphier 1,000
Last 10 Sell Shares
Edward O. Lanphier 1,000
H. Ward Wolff 1,000
H. Ward Wolff 1,000
H. Ward Wolff 1,000
Edward O. Lanphier 1,000
H. Ward Wolff 1,000
H. Ward Wolff 1,000
Dale G. Ando 1,000
William R. Ringo 1,000
Philip D. Gregory 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 30 30 30 30
Low Target Price Estimate 8 8 14 8
Mean Target Price Estimate 17.25 17 18.4 15.25
Standard Deviation 9.29 8.06 6.58 10.18
Date of Most Recent Estimate 08/04/16 08/04/16 05/06/16 08/12/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 7 7 7
Moderate Buy 0 0 0 0
Hold 1 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.33 1 1 1